|
|
Volumn 174, Issue SUPPL. 1, 1996, Pages
|
|
Efficacy of a quadrivalent rhesus rotavirus-based human rotavirus vaccine aimed at preventing severe rotavirus diarrhea in infants and young children
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
CAPSID PROTEIN;
GENE PRODUCT;
NEUTRALIZING ANTIBODY;
ORAL REHYDRATION SOLUTION;
PLACEBO;
ROTAVIRUS VACCINE;
SIMIAN ROTAVIRUS VACCINE;
ANIMAL CELL;
CHILD;
CLINICAL TRIAL;
CONFERENCE PAPER;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DISEASE SEVERITY;
DRUG EFFICACY;
FEVER;
GNOTOBIOTICS;
HUMAN;
HUMAN ROTAVIRUS;
INFANT;
INFANTILE DIARRHEA;
INOCULATION;
MAJOR CLINICAL STUDY;
MULTICENTER STUDY;
NEWBORN;
NONHUMAN;
ORAL DRUG ADMINISTRATION;
PHASE 1 CLINICAL TRIAL;
PHASE 2 CLINICAL TRIAL;
PRIORITY JOURNAL;
RANDOMIZED CONTROLLED TRIAL;
SEROTYPE;
VACCINATION;
VIRUS CAPSID;
VIRUS GENE;
VIRUS SHEDDING;
|
|
EID: 0029834988
PISSN: 00221899
EISSN: None
Source Type: Journal
DOI: 10.1093/infdis/174.supplement_1.s65 Document Type: Conference Paper |
|
Times cited : (186)
|
|
References (0)
|
